Skip to content
Amylyx Pharmaceuticals Inc icon

Amylyx Pharmaceuticals Inc

AMLXStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$26.00

Today

-0.7%

YTD

+115.6%

About

Amylyx Pharmaceuticals Inc is a leading pharmaceutical company committed to providing novel treatments for life-threatening neurodegenerative disorders. Operating from the US, it has a thriving presence across North America and Europe. Functioning within the fast-paced healthcare industry, Amylyx Pharmaceuticals focuses primarily on neuroscience. The firm’s unique approaches to battling neurodegenerative diseases mark it as an innovative player in the sector. Its operations extend to a network of global partners, enhancing their capacity to provide quality healthcare solutions. Monitor the AMLX share price by adding it to your eToro watchlist today.

Price chart
Closing price history for AMLX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-17.98
P/S (TTM)0.00
P/B (TTM)4.44
Market cap$3.35B
Cap tierMid-cap
Industry avg P/E-17.91

Profitability

Gross margin-43.68%
EBIT margin0.00%
Net margin-17476.92%
ROE-30.06%
ROA-28.39%

Earnings & Revenue

Revenue (TTM)$0.00
Revenue growth (1Y)-100.0%
EPS (TTM)-$1.45
Free cash flow$-130.02M
Total debt$4.94M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.69
Employees136
Next earnings4 Mar '27
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Amylyx Pharmaceuticals Inc (AMLX) | Dirk Kuyken